ArticleCardio-oncology (London, England)2025

Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane (PHOENIX Study): dose response and time course of dexrazoxane-induced degradation of topoisomerase 2b.

Hui-Ming Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.